MedDeviceGuide — IVD & Medical Device Knowledge Base

Complete guide to digital health and AI medical device regulation across MENA — SFDA MDS-G27 guidance on digital health products (SaMD, mHealth, DTx, AI/ML, telemedicine, wearables, VR/AR), UAE EDE AI registration frameworks and National AI Strategy 2031, Turkey TITCK software medical device classification and exclusion list, Israel AMAR software requirements, and practical compliance strategies for each market.

Complete guide to registering medical devices in Egypt through the Egyptian Drug Authority (EDA) — EU MDR-aligned classification, MeDevice portal, ERH requirements, fees, timelines, and the February 2026 simplification measures for the $4.37B market.

How to register medical devices across the smaller GCC states — Kuwait Decree 387/2025, Bahrain NHRA mandatory registration, Oman MOH Class C/D portal, Qatar MOPH requirements, and Gulf Health Council harmonization.

How the IMDRF Reliance Playbook, MDSAP expansion, ASEAN single submission framework, and national reliance pathways are reshaping global medical device registration in 2026 — with practical strategies for manufacturers to streamline multi-market access.

A practical regulatory strategy guide for medical device startups — covering FDA pathway selection, budget planning, Q-Sub pre-submissions, eSTAR templates, QMSR compliance, fundraising alignment, and the programs that accelerate market entry in 2026.

How US tariffs, EU-China trade tensions, and Mexico's new tariff law are reshaping global medtech supply chains in 2026 — with real financial impacts from J&J, Intuitive Surgical, Boston Scientific, and practical strategies for manufacturers.

Complete guide to in vitro diagnostic (IVD) registration across MENA — Saudi SFDA IVD classification (A–D) and companion diagnostic guidance, UAE EDE IVD requirements and fees, Egypt EDA IVD classes with ISO 15189/CLSI performance evaluation, Turkey TITCK IVDR-aligned framework, Israel AMAR IVD declaration route, and point-of-care testing requirements.

Complete guide to medical device clinical trial requirements across MENA — Saudi SFDA MDS-REQ-2 clinical trial framework (295 studies evaluated, 157 approved), UAE clinical investigation pathways, Egypt EDA Clinical Trials Law 214/2020 with three authorization pathways, Turkey TITCK Regulation on Clinical Trials, Israel MOH oversight, Qatar Law 6/2025, and practical strategies for multi-country trial management.

Practical guide to medical device import, customs duties, and free zone strategies across MENA — GCC Common Customs Tariff (5% standard rate), Saudi SABER/ZATCA procedures and 2026 tariff code updates, UAE EDE import requirements and free zone advantages (DHCC, DSP), Egypt EDA import approval and customs clearance, Turkey TITCK import controls, and optimization strategies for duty reduction.

Comprehensive analysis of the Middle East & North Africa medical device market — $24.6B in 2025 growing to $35B by 2032 at 5.1% CAGR. Saudi Arabia's $35.5B Global Health Exhibition deals, 400 GCC healthcare transactions (2021–2025), UAE $3.18B market, Egypt $4.37B, digital health at 19.6% CAGR, and smart devices growing at 10.16% CAGR.

How medical devices get reimbursed across MENA — Saudi Arabia CHI/NPHIES/AR-DRG value-based system, UAE mandatory insurance (Daman/Thiqa/AED 320 basic plan), Turkey SGK SUT codes and DMO procurement, Israel Health Basket, and Egypt UHIA universal insurance rollout. Market data, fees, co-payments, and market access strategies for device manufacturers.

Complete guide to post-market surveillance and vigilance requirements for medical devices across MENA — SFDA MDS-REQ11 (2-day/10-day/30-day reporting, change notifications, 90-day renewal), UAE EDE biennial PSUR for high-risk devices, Turkey TITCK 6-month shortage notification, Israel IRH periodic post-marketing reports, and Egypt EDA vigilance obligations.

Complete guide to medical device registration in North Africa — Morocco AMMPS/DMP (120 days, 5-year validity, 2026 local manufacturing pact), Algeria ANPP serialization framework (GS1 2D DataMatrix by 2027), and Tunisia DPM/ANMPS requirements including eCTD mandate from June 2026.

How Saudi Arabia's HSTP (290 hospitals privatized, private sector 40% to 65%, SAR 260B health budget, LCGPA 40% local content, NIDLP 40% pharma localization) and UAE's Operation 300bn (AED 300B industrial GDP target, DHCC 100% foreign ownership, EDE regulatory framework) are reshaping medical device market entry across the Gulf.

How to register medical devices in the UAE under the Emirates Drug Establishment (EDE) — classification, fees, LAR requirements, DHA vs DOH differences, and the full step-by-step process after the 2026 MOHAP transition.

A data-driven tracker of every major medtech M&A deal in 2025 and 2026 — from Abbott's $21B Exact Sciences acquisition to Boston Scientific's $14.5B Penumbra buy — with deal values, strategic rationale, and industry trends.

A data-driven analysis of why cardiovascular devices dominate medtech M&A — covering the Stryker/Inari, Boston Scientific/Penumbra, and Medtronic/CathWorks deals, the PFA revolution, structural heart innovation, and the forces driving CV dealmaking in 2025-2026.

A complete guide to registering medical devices in Chile through ISP (Instituto de Salud Pública). Covers the four-class risk system, GICONA registration platform, documentation requirements, fees, timelines, and the new March 2026 decree expanding mandatory registration to 39 additional device categories.

A complete guide to the European Commission's December 2025 proposal to simplify MDR and IVDR. Covers the new Rule 11 for software, indefinite certificate validity, regulatory sandboxes, breakthrough and orphan device pathways, fixed conformity timelines, SME fee reductions, and the expected legislative timeline through 2027.

An in-depth analysis of how the Federal Trade Commission is reshaping medtech dealmaking — from blocking the Edwards/JenaValve TAVR deal to the GTCR/Surmodics outcome, HSR filing changes, and the rise of state-level mini-HSR laws.